RapiDx Overview

  • Founded
  • 2008
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Investors
  • 3

RapiDx General Information


Developer of a blood-testing device designed to draw blood from the finger easily and painlessly. The company's device is used for self-use blood tests such as cardiac markers, PSA, HIV, TSH and cholesterol, enabling users to draw blood without the need of a medical professional.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 132 Menachem Begin Street
  • Azrieli Triangle Tower
  • Tel Aviv 67023
  • Israel
+972 00-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

RapiDx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 10-Oct-2016 00.00 Completed Generating Revenue
2. Early Stage VC 23-Jan-2011 00.00 00.00 Completed Generating Revenue
1. Seed Round 29-Jul-2008 $1M $1M Completed Startup
To view RapiDx’s complete valuation and funding history, request access »

RapiDx Board Members (3)

Name Representing Role Since
Chen Katz TechnoPlus Ventures Board Member 000 0000
David Akunis Medvest Board Member 000 0000
Hezi Aspis Self Board Member 000 0000
To view RapiDx’s complete board members history, request access »

RapiDx Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Brevard Health Alliance Inc. Corporation 000 0000 000000 0
Medvest Angel Group Minority 000 0000 000000 0
TechnoPlus Ventures PE/Buyout Minority 000 0000 000000 0
To view RapiDx’s complete investors history, request access »